Architecture of the subthalamic nucleus

Area of Science:

• Neuroscience
• Molecular Biology
• Neuromodulation

Background:

• The subthalamic nucleus (STN) is a critical target for deep brain stimulation (DBS) in neurological and neuropsychiatric disorders.
• Current understanding of the STN's internal organization is limited, hindering precise therapeutic interventions.
• STN-DBS is used for Parkinson's disease, dystonia, essential tremor, and OCD, with potential for Tourette syndrome.

Purpose of the Study:

• To outline the neurobiological architecture of the STN.
• To emphasize the molecular patterns and spatio-molecular heterogeneity within the STN.
• To explore how understanding STN's molecular organization can advance precision medicine.

Main Methods:

• Review of recent gene expression studies in human, non-human primate, and rodent brains.
• Analysis of anatomical distribution of specific molecular markers.
• Integration of spatio-molecular data to understand STN architecture.

Main Results:

• Gene expression studies reveal spatio-molecular heterogeneity within the STN.
• Specific molecular markers show defined anatomical distributions across species.
• The STN exhibits a complex, heterogeneous molecular architecture.

Conclusions:

• The STN possesses a heterogeneous molecular architecture, crucial for its diverse functional roles.
• Molecular profiling of the STN is essential for advancing precision in clinical DBS interventions.
• Understanding STN's molecular landscape can improve therapeutic outcomes for severe brain disorders.